Drugs Developed with Dutch Public Funding
This report examines the extent of Dutch public funding of drug development, through donations, loans and/or investments. This funding occurs both directly by financing development of new medicines, and indirectly through investments made into biotech companies, but channelled through universities, public research bodies, and national and regional investment funds.
A Dutch summary of the report is available as well.
Do you need more information?
Download: Report Overpriced def (pdf, 1.05 MB)
Pharma’s pandemic profits Published on:Esther de HaanPosted in category:PublicationEsther de Haan